Trademark Attorney / Law Firm
Michael R. Christensen – Trademark Portfolio
Michael R. Christensen specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 11 of 16 total filings concentrated in this category. The practice also covers Class 10 (Medical Apparatus) along with 3 other Nice Classification classes. Filing activity spans from 1997 to 2025. Currently, 10 trademarks are registered and 2 are pending.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Michael R. Christensen's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademark applications has Michael R. Christensen filed?
Michael R. Christensen has filed 16 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 10 registered, 2 pending, 2 abandoned, 2 cancelled.
What trademark classes does Michael R. Christensen specialize in?
Michael R. Christensen has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has Michael R. Christensen been filing trademarks?
Michael R. Christensen's trademark filing history with the USPTO spans from 1997 to 2025, covering 28 years of trademark practice. During this period, Michael R. Christensen has handled 16 trademark applications.
What is Michael R. Christensen's trademark registration success rate?
Michael R. Christensen has a 71% trademark registration rate, with 10 out of 14 resolved applications resulting in successful registration. Currently, 2 applications are pending review.